Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
Ozempic Shows Some Promise for Alcohol Use Disorder
US News and World Report
Wed, 02/12/25 - 09:26 pm
Novo Nordisk
Ozempic
alcohol-use disorder
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Clinical Trials Arena
Fri, 02/7/25 - 11:42 am
Novo Nordisk
CagriSema
obesity
clinical trials
Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect
Fierce Biotech
Fri, 02/7/25 - 11:02 am
Novo Nordisk
hemophilia A
Mim8
pediatric
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Yahoo/Reuters
Thu, 02/6/25 - 11:40 am
Novo Nordisk
tariffs
Europe
Donald Trump
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
CNBC
Wed, 02/5/25 - 10:42 pm
Novo Nordisk
Wegovy
earnings
Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects
Fierce Biotech
Wed, 02/5/25 - 11:21 am
Novo Nordisk
clinical trials
diabetic kidney disease
Monlunabant
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Yahoo/Reuters
Tue, 02/4/25 - 06:11 pm
Novo Nordisk
CagriSema
Forget Wegovy: Novo Nordisk May Have a New Billion-Dollar Weight Loss Drug On Its Hands
Motley Fool
Mon, 02/3/25 - 11:55 am
Novo Nordisk
obesity
amycretin
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Fri, 01/31/25 - 10:59 am
surgery
GLP-1 agonists
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Zepbound
Mounjaro
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thu, 01/30/25 - 11:33 am
Novo Nordisk
CagriSema
clinical trials
obesity
FDA approves new indication for Ozempic to lower kidney risks in type 2 diabetes, CKD
Healio
Tue, 01/28/25 - 09:42 pm
Novo Nordisk
FDA
Ozempic
kidney disease
Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial
Fierce Biotech
Tue, 01/28/25 - 10:17 am
Veru
obesity
Novo Nordisk
enobosarm
Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
MSN/Reuters
Mon, 01/27/25 - 10:51 pm
Minnesota
Novo Nordisk
insulin
drug pricing
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Fierce Biotech
Fri, 01/24/25 - 11:47 am
Novo Nordisk
amycretin
obesity
clinical trials
Novo Nordisk gets BACH1, inking IMMvention deal to orchestrate attack on sickle cell disease
Fierce Biotech
Wed, 01/22/25 - 11:55 am
Novo Nordisk
sickle cell disease
IMMvention Therapeutix
Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's
Fierce Pharma
Tue, 01/21/25 - 07:13 pm
Novo Nordisk
Eli Lilly
GLP-1 agonists
Wegovy
Ozempic
Zepbound
Mounjaro
Alzheimer's disease
arthritis
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Fierce Pharma
Fri, 01/17/25 - 11:34 am
Novo Nordisk
obesity
semaglutide
Wegovy
Eli Lilly
Zepbound
clinical trials
Ozempic tops new Medicare price negotiation list
Pharmaphorum
Fri, 01/17/25 - 11:10 am
Novo Nordisk
Ozempic
Wegovy
Rybelsus
HHS
Inflation Reduction Act
Medicare
5 questions facing pharma in 2025
BioPharma Dive
Fri, 01/10/25 - 11:47 am
Donald Trump
obesity
Novo Nordisk
Eli Lilly
vaccines
pharma stocks
regulatory
immunology
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »